Clinical Trial Update: CANagliflozin In DIALysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating canagliflozin in patients on dialysis for chronic kidney disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Invokana (canagliflozin) (canagliflozin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Dialysis, Chronic Kidney Disease (Stages 4 and 5) | Phase 4 | Status: NOT_YET_RECRUITING